Drug-Induced Liver Disease

@article{Zimmerman2012DrugInducedLD,
  title={Drug-Induced Liver Disease},
  author={Hyman J. Zimmerman},
  journal={Drugs},
  year={2012},
  volume={16},
  pages={25-45}
}
SummaryThe large number of chemical agents administered for therapeutic or diagnostic purposes can produce various types of hepatic injury by several mechanisms. Acute injury may be cytotoxic, cholestatic or mixed. Cytotoxic injury may consist of necrosis or steatosis. Cholestatic injury may be cholangiolitic (hepatocanalicular) or bland (canalicular). Chronic hepatic lesions caused by medicinal agents include chronic active hepatitis, steatosis, cirrhosis, fibrosis, hepatoportal sclerosis (non… 
Drug -induced liver injury: A review
TLDR
The incidence of drug induced liver injury (DILI) is about 1/1000 to 1/10000 among patients who receive therapeutic drug doses and treatment options include discontinuing the drug, conservative measurements and liver transplantation in the case of non-acetaminophen induced hepatotoxicity.
Drug-induced liver injury.
Toxin- and Drug-Induced Pathologies
TLDR
Although histological findings following the ingestion of heavy metals have been described in the literature, these are rarely seen in routine practice and are seen in conjunction with suicides, e.g., using English yew or tobacco.
Toxins mechanism in instigating hepatotoxicity
TLDR
This review focuses on providing an overview of the plausible mechanisms of action of various intrinsic and idiosyncratic hepatotoxic drugs that involve various molecular and cellular elements in hepatotoxicity and cell death.
Drug-Induced Liver Injuries (Clinical Guidelines for Physicians)
TLDR
The presented clinical recommendations contain information about the epidemiological data, terminology, diagnostic principles, classification, prognosis and management of patients with DILI, and list pharmacological agents that most commonly cause DILi, including its fatal cases.
Drug Prescribing in Hepatobiliary Disease
TLDR
Caution should be exercised in prescribing drugs to patients with liver disease and the dose should be titrated to the clinical response and the development of liver function’ tests using model or marker drugs may offer some help to the prescriber in the future and enable a less empirical approach.
Liver involvement in the drug reaction, eosinophilia, and systemic symptoms syndrome
TLDR
The literature of previously reported case-series of DReSS and liver involvement is reviewed, highlighting the pattern of liver damage, the treatment used, and the outcome.
Liver Safety Assessment in Special Populations (Hepatitis B, C, and Oncology Trials)
TLDR
The lack of consensus in defining stopping rules based on serum alanine aminotransferase levels underscores the need for precompetitive data sharing to improve understanding of DILI in populations with underlying liver disease and to allow evidence-based rather than empirical definition of stopping rules.
Nonsteroidal anti-inflammatory drug-induced hepatoxicity.
...
...

References

SHOWING 1-10 OF 129 REFERENCES
Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis.
The clinical spectrum of isoniazid-induced liver injury seems to be clinically, biochemically, and histologically indistinguishable from viral hepatitis, except that the injury occurs primarily in
ALTERATIONS OF LIVER AND SPLEEN AMONG WORKERS EXPOSED TO VINYL CHLORIDE
TLDR
Preliminary review of hepatic biopsy and autopsy specimens obtained from workers engaged for prolonged periods in the polymerization of vinyl chloride indicates a fibrotic precursor lesion in the liver that is presumably the result of stimulation of various hepatic as well as splenic cells by vinyl chloride or its metabolites.
Massive hepatic necrosis in a patient receiving allopurinol.
TLDR
A fatal outcome of acute, massive, hepatic necrosis in a patient receiving allopurinol for asymptomatic hyperuricemia is reported.
Drug-induced active chronic hepatitis
TLDR
In an investigation of the etiology of 21 consecutive cases of active chronic hepatitis presenting for the first time in the last 12 months, 14 cases considered to be drug-induced showed clinical and biochemical improvement after drug withdrawal, and 3 months later the change in their liver function was greater than in cases of unknown etiology.
Drug-induced active chronic hepatitis
TLDR
In an investigation of the etiology of 21 consecutive cases of active chronic hepatitis presenting for the first time in the last 12 months, 14 cases considered to be drug-induced showed clinical and biochemical improvement after drug withdrawal, and 3 months later the change in their liver function was greater than in cases of unknown etiology.
Liver Damage due to Methotrexate in Patients with Psoriasis
TLDR
It appears that methotrexate, in the doses normally used to control psoriasis, may cause cirrhosis if treatment is prolonged and that liver biopsy is necessary for evaluation of liver damage in these patients.
Active chronic hepatitis after chlorpromazine ingestion.
TLDR
The two patients were previously healthy young people who developed a 'flu-like illness during a minor epidemic of influenza A that produced acute renal failure while in the second a severe consumption coagulopathy produced defibrination, intrapulmonary haemorrhage, and death.
...
...